Percy Carter, MBA, PhD
Percy is the Head of Discovery, Chemistry and Molecular Technologies at BMS. He leads a team responsible for discovering drug candidates across therapeutic areas and molecular platforms. His role requires collaboration across teams in multiple sites, including in the U.S. and India, to discover clinical candidates.
Michael M. Miller, MBA, PhD
Michael is the Head, Alternative Partnership Models at Bristol-Myers Squibb. He leads a unique function called Alternative Partnership Models at Bristol-Myers Squibb seeking creative deal structures for the organization's strategic in-licensing and out-licensing activities, as well as defining flexible frameworks to externalize R&D efforts while successfully advancing the current and future portfolio.